ATM and non-small cell lung carcinoma: In an attempt to clearly elucidate the mechanism of the tumoricidal activity of pemetrexed in NSCLC, we previously identified components of the ERK and ATM signaling pathways as toxic determinants of pemetrexed in NSCLC A549 and H1299 cell lines [21], [22].